Larvol Delta - The-Drug-Reimbursement-Evaluation-Committeealso-recognized-the-appropriateness-for-coverage-of-treatments-for-myasthenia-gravis

Zilbrysq (zilucoplan) - UCB

Vyvgart (efgartigimod alfa-fcab) - argenx, Broteio

https://biz.chosun.com/en/en-science/2026/09/04/3MN3I7CCUZC4JDJ2DVVHYUP744/

Sep 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next